Régis Saleur

Amministratore Delegato presso

CEA Investissement SA

58 anni

22 relazioni

Electronic Technology

Health Technology

Commercial Services

Profilo

Régis Saleur currently works at CEA Investissement SA, as Chief Executive Officer from 2008, ETHERA SA, as Director, SymbioFCell SA, as Director, Haption SA, as Member-Supervisory Board, and Supernova Invest SAS, as Managing General Partner from 2017.
Mr. Saleur also formerly worked at Avenium Consulting SA, as Chairman-Supervisory Board, Krono-Safe SA, as Director, Neorphys SAS, as Director, Neurokin SA, as Director, Eye Tech Care SA, as Director, Sports Medias et Strategie SA, as Director, Fermentalg SA, as Director, Nexess SA, as Director, Aselta Nanographics SAS, as Director, Pegastech SA, as Director, PV Alliance SASU, as Director, Algaïa SA, as Director, Nanomakers SA, as Director, THX Pharma, as Director, Bioaxial SAS, as Director, Prestodiag SAS, as Director, Genes'Ink SAS, as Director, NAWATechnologies SA, as Director, Advanced Magnetic Interaction, AMI SAS, as Director, Kalray SA, as Member-Supervisory Board, Galileo Partners SA, as Associé from 2004 to 2007, Galileo Partners SA, as General Partner, Aveni SA, as Member-Censer Board, Crocus Technology International Corp., as Member-Censor Board, Tronic's Microsystems SA, as Member-Supervisory Board, CYTOO SA, as Member-Supervisory Board, Multix SA, as Member-Supervisory Board, Robotiques 3 Dimensions SA, as Member-Supervisory Board, Arcure SA, as Member-Supervisory Board, and Aledia SAS, as Member-Censor Board.
Mr. Saleur received his undergraduate degree from École Centrale Paris.

Posizioni attive di Régis Saleur

Società	Posizione	Inizio
CEA Investissement SA CEA Investissement SA Investment ManagersFinance CEA-I focuses on high-technology sectors where CEA conducts research. In particular, CEA-I has scientific and technical expertise in micro- and nano-technologies, biotechnology and medical technology, systems and software, advanced materials and innovation in the field of energy. The firm specializes in seed capital and early-stage investment in businesses based either on CEA research or on third-party research in a domain where CEA has expertise. CEA-I invests exclusively in the first financing round or before, generally in syndication with other venture capital firms. The firm acquires minority stakes, investing on average 500 thousand Euros. They seek board representation and participate in strategic decisions without interfering in daily operations. Their targeted exit horizon is five to eight years. Exit strategies include IPO and resale to financial or industrial partners. CEA-I also invests indirectly in early-stage French companies, in particular through funds managed by Grenoble-based venture capital firm Emertec Gestion in which they hold a minority interest.	Amministratore Delegato	01/06/2008
SymbioFCell SA SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems	Direttore/Membro del Consiglio	-
ETHERA SA ETHERA SA Medical SpecialtiesHealth Technology Develops diagnostic kits for indoor air pollution	Direttore/Membro del Consiglio	-
Haption SA Haption SA Computer PeripheralsElectronic Technology Develops and commercializes computer devices for virtual reality	Direttore/Membro del Consiglio	-
Supernova Invest SAS Supernova Invest SAS Investment ManagersFinance Supernova Invest is an active manager which invests in start-ups in France manly but also worldwide. It participates in venture capital funding, from seed stage to growth stage. It focuses on sectors such as health technologies, energy & environment, industry and electronic technologies. Supernova Invest usually takes board seats in the company it invests in.	Investitore di Private Equity	01/03/2017

Tutte le posizioni attive di Régis Saleur

Precedenti posizioni note di Régis Saleur

Società	Posizione	Fine
Neorphys SAS Neorphys SAS Pharmaceuticals: MajorHealth Technology Discovers and develops novel lifestyle drug candidates	Direttore/Membro del Consiglio	11/03/2014
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Direttore/Membro del Consiglio	11/03/2014
Galileo Partners SA Galileo Partners SA Investment ManagersFinance Galileo is an active venture capital investment manager specialized in high-technology industries. The firm invests in expanding sectors such as information technology, software, electronics, semi-conductors, telecommunications, new media and specialized e-commerce, as well as in medical technology. They avoid biotechnology companies. Galileo invests in Europe across development stages, including early-stage, expansion financing, turnarounds, spin-offs, leveraged buyouts and special situations, with a strong focus on French companies with international growth potential. Galileo's investment philosophy emphasizes flexibility, reactivity and diversification. The firm follows a hands-on investment approach, usually acquires minority stakes and systematically seeks board representation. Their initial investments range from 1 to 5 million Euros, up to 10 millions over several financing rounds. Galileo invests both as the lead investor and in syndication. All investment decisions are collegiate and unanimous. The firm's exit strategies include IPOs and trade sales.	Membro del Comitato di Investimento	01/06/2007
Multix SA Multix SA Miscellaneous Commercial ServicesCommercial Services Manufactures spectrometric X-ray	Direttore/Membro del Consiglio	-
░░░░░░░ ░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

Vedi nel dettaglio l'esperienza di Régis Saleur

Formazione di Régis Saleur

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Régis Saleur

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	35
Galileo Partners SA Galileo Partners SA Investment ManagersFinance Galileo is an active venture capital investment manager specialized in high-technology industries. The firm invests in expanding sectors such as information technology, software, electronics, semi-conductors, telecommunications, new media and specialized e-commerce, as well as in medical technology. They avoid biotechnology companies. Galileo invests in Europe across development stages, including early-stage, expansion financing, turnarounds, spin-offs, leveraged buyouts and special situations, with a strong focus on French companies with international growth potential. Galileo's investment philosophy emphasizes flexibility, reactivity and diversification. The firm follows a hands-on investment approach, usually acquires minority stakes and systematically seeks board representation. Their initial investments range from 1 to 5 million Euros, up to 10 millions over several financing rounds. Galileo invests both as the lead investor and in syndication. All investment decisions are collegiate and unanimous. The firm's exit strategies include IPOs and trade sales.	Finance
Aveni SA Aveni SA Chemicals: Major DiversifiedProcess Industries Designs, develops, manufactures and markets chemical formulations	Process Industries
Haption SA Haption SA Computer PeripheralsElectronic Technology Develops and commercializes computer devices for virtual reality	Electronic Technology
École Centrale Paris École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Crocus Technology International Corp. Crocus Technology International Corp. SemiconductorsElectronic Technology Develops magnetically enhanced semiconductor technologies	Electronic Technology
CEA Investissement SA CEA Investissement SA Investment ManagersFinance CEA-I focuses on high-technology sectors where CEA conducts research. In particular, CEA-I has scientific and technical expertise in micro- and nano-technologies, biotechnology and medical technology, systems and software, advanced materials and innovation in the field of energy. The firm specializes in seed capital and early-stage investment in businesses based either on CEA research or on third-party research in a domain where CEA has expertise. CEA-I invests exclusively in the first financing round or before, generally in syndication with other venture capital firms. The firm acquires minority stakes, investing on average 500 thousand Euros. They seek board representation and participate in strategic decisions without interfering in daily operations. Their targeted exit horizon is five to eight years. Exit strategies include IPO and resale to financial or industrial partners. CEA-I also invests indirectly in early-stage French companies, in particular through funds managed by Grenoble-based venture capital firm Emertec Gestion in which they hold a minority interest.	Finance
Tronic's Microsystems SA Tronic's Microsystems SA SemiconductorsElectronic Technology Designs and manufactures micro electro mechanical systems	Electronic Technology
Neorphys SAS Neorphys SAS Pharmaceuticals: MajorHealth Technology Discovers and develops novel lifestyle drug candidates	Health Technology
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Health Technology
CYTOO SA CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays	Health Technology
Eye Tech Care SA Eye Tech Care SA Medical SpecialtiesHealth Technology Develops medical devices for non-invasive eye disease treatment	Health Technology
Sports Medias et Strategie SA Sports Medias et Strategie SA Publishing: NewspapersConsumer Services Publishes and supplies weekly sports magazines and newspapers	Consumer Services
Kalray SA Kalray SA SemiconductorsElectronic Technology Develops, markets, and sells processors	Electronic Technology
Fermentalg SA Fermentalg SA Food: Specialty/CandyConsumer Non-Durables Manufactures coloring powers, extracts and concentrates for food, cosmetics and pharmaceutical industry	Consumer Non-Durables
Nexess SA Nexess SA Miscellaneous Commercial ServicesCommercial Services Specialist in safety & security solutions	Commercial Services
Avenium Consulting SA Avenium Consulting SA Miscellaneous Commercial ServicesCommercial Services Provides consulting services in industrial property patents	Commercial Services
Aselta Nanographics SAS Aselta Nanographics SAS SemiconductorsElectronic Technology Produces virtually chip and display equipment	Electronic Technology
Pegastech SA Pegastech SA TextilesProcess Industries Provides surface treatment and coating processes	Process Industries
PV Alliance SASU PV Alliance SASU Electric UtilitiesUtilities Produces solar panels and photo-electric cells	Utilities
ETHERA SA ETHERA SA Medical SpecialtiesHealth Technology Develops diagnostic kits for indoor air pollution	Health Technology
Algaïa SA Algaïa SA Agricultural Commodities/MillingProcess Industries Produces and sells seaweed, algae & other plant-based products	Process Industries
SymbioFCell SA SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems	Producer Manufacturing
Multix SA Multix SA Miscellaneous Commercial ServicesCommercial Services Manufactures spectrometric X-ray	Commercial Services
Nanomakers SA Nanomakers SA Metal FabricationProducer Manufacturing Designs and manufactures silicon carbide nanopowders	Producer Manufacturing
Robotiques 3 Dimensions SA Robotiques 3 Dimensions SA Miscellaneous Commercial ServicesCommercial Services Specializes in the design and manufacture of collaborative robots	Commercial Services
Arcure SA Arcure SA Telecommunications EquipmentElectronic Technology Designs and markets an intelligent solutions to prevent collisions between vehicles	Electronic Technology
Krono-Safe SA Krono-Safe SA Packaged SoftwareTechnology Services Provides software solutions for the development of embedded systems	Technology Services
Aledia SAS Aledia SAS Electrical ProductsProducer Manufacturing Develops and manufactures light-emitting diodes	Producer Manufacturing
Theranexus SA Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases	Health Technology
Bioaxial SAS Bioaxial SAS Electronic ComponentsElectronic Technology Develops technology for fluorescence microscopy	Electronic Technology
Prestodiag SAS Prestodiag SAS Miscellaneous Commercial ServicesCommercial Services Specialized in life science developments.	Commercial Services
Genes'Ink SAS Genes'Ink SAS BiotechnologyHealth Technology Research in the design and manufacture of active nanoparticles	Health Technology
NAWATechnologies SA NAWATechnologies SA Electric UtilitiesUtilities Provides materials and products based on nanostructures	Utilities
Advanced Magnetic Interaction, AMI SAS Advanced Magnetic Interaction, AMI SAS Computer Processing HardwareElectronic Technology Develops and markets graphic tablets	Electronic Technology
Supernova Invest SAS Supernova Invest SAS Investment ManagersFinance Supernova Invest is an active manager which invests in start-ups in France manly but also worldwide. It participates in venture capital funding, from seed stage to growth stage. It focuses on sectors such as health technologies, energy & environment, industry and electronic technologies. Supernova Invest usually takes board seats in the company it invests in.	Finance